Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.310
-0.040 (-2.96%)
At close: Dec 5, 2025, 4:00 PM EST
1.320
+0.010 (0.76%)
After-hours: Dec 5, 2025, 7:46 PM EST
Phio Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 14 | 3 | 2 | 5 | 14 | 16 | |
| Market Cap Growth | 423.65% | 67.92% | -63.48% | -62.43% | -12.96% | 146.99% | |
| Enterprise Value | 3 | -2 | -6 | -9 | -13 | -1 | |
| Last Close Price | 1.31 | 1.80 | 6.84 | 40.18 | 108.00 | 290.52 | |
| Forward PE | - | 0.13 | 0.21 | 0.37 | 2.19 | - | |
| PB Ratio | 0.77 | 0.66 | 0.24 | 0.47 | 0.62 | 1.20 | |
| P/TBV Ratio | 1.43 | 0.66 | 0.24 | 0.47 | 0.62 | 1.20 | |
| Debt / Equity Ratio | - | - | 0.01 | 0.02 | 0.01 | 0.05 | |
| Quick Ratio | 6.43 | 5.30 | 5.20 | 6.08 | 7.84 | 6.49 | |
| Current Ratio | 6.90 | 5.65 | 5.71 | 6.42 | 8.06 | 6.91 | |
| Return on Equity (ROE) | -107.58% | -114.83% | -116.60% | -70.06% | -76.04% | -93.73% | |
| Return on Assets (ROA) | -60.16% | -61.14% | -60.30% | -37.72% | -41.28% | -46.22% | |
| Return on Capital (ROIC) | -70.68% | -73.94% | -71.23% | -43.11% | -47.06% | -55.16% | |
| Return on Capital Employed (ROCE) | -85.00% | -156.40% | -138.40% | -105.40% | -61.10% | -64.90% | |
| Earnings Yield | -56.40% | -229.29% | -582.98% | -225.78% | -98.17% | -56.55% | |
| FCF Yield | -51.65% | -228.10% | -579.10% | -240.93% | -87.99% | -56.73% | |
| Buyback Yield / Dilution | -569.57% | -240.15% | -83.32% | -6.30% | -179.70% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.